Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.

[1]  A. Vimercati,et al.  Polycystic ovary syndrome: relationship between insulin sensitivity ,sex hormone levels and ovarian stromal blood flow , 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[2]  F. Petraglia,et al.  Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome. , 2000, Human reproduction.

[3]  R. Jaffe,et al.  Role of vascular endothelial growth factor in ovarian physiology and pathology. , 2000, Fertility and sterility.

[4]  L. Giudice,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome* , 2022 .

[5]  C. Gordon,et al.  Polycystic ovary syndrome. , 1999, Adolescent medicine.

[6]  M. Bottomley,et al.  Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. , 1998, Clinical science.

[7]  S. Campbell,et al.  Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. , 1998, Human reproduction.

[8]  M. Antczak,et al.  The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. , 1997, Human reproduction.

[9]  J. Schenker,et al.  Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. , 1997, Fertility and sterility.

[10]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[11]  D. Donner,et al.  Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma* , 1996, The Journal of Biological Chemistry.

[12]  M. Predanic,et al.  Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. , 1996, Fertility and sterility.

[13]  Z. Rosenwaks,et al.  Reproductive endocrinology, surgery, and technology , 1996 .

[14]  Phillip D. K. Lee,et al.  Altered Regulation of Insulin-Like Growth Factor Binding Protein-I in Patients With Polycystic Ovary Syndrome , 1995, The Journal of the Society for Gynecologic Investigation: JSGI.

[15]  S. Campbell,et al.  Ovarian stromal blood flow in women with polycystic ovaries--a possible new marker for diagnosis? , 1995, Human reproduction.

[16]  G. Kaltsas,et al.  Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. , 1995, Human reproduction.

[17]  M. Breckwoldt,et al.  Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. , 1995, The Journal of clinical endocrinology and metabolism.

[18]  R. Buyalos,et al.  Insulin-like growth factors: clinical experience in ovarian function. , 1995, The American journal of medicine.

[19]  E. Manseau,et al.  Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. , 1995, American Journal of Pathology.

[20]  B. Carlsson,et al.  Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. , 1993, Fertility and sterility.

[21]  L. Giudice.  Insulin-like growth factors and ovarian follicular development. , 1992, Endocrine reviews.

[22]  D. Connolly.  Vascular permeability factor: A unique regulator of blood vessel function , 1991, Journal of cellular biochemistry.

[23]  D. Magoffin,et al.  The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. , 1990, The Journal of clinical endocrinology and metabolism.

[24]  M. Iwashita,et al.  Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome. , 1990, Hormone research.

[25]  D. Magoffin,et al.  Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. , 1989, The Journal of clinical endocrinology and metabolism.

[26]  J. Findlay.  Angiogenesis in reproductive tissues. , 1986, The Journal of endocrinology.

[27]  J. Price,et al.  MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.

[28]  A. Zeleznik,et al.  Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. , 1981, Endocrinology.